Parizel and van Hecke: Integrity in Imaging Trials
How to Keep Your Integrity When Performing Sponsored (Imaging) Trials
Paul M. Parizel MD, PhD, Wim van Hecke, PhD
The broadening of imaging capabilities and the increasing capacity of imaging to quantitate biologic processes has increased industry interest in using imaging methods in new drug development. Investigators participating in industry-sponsored trials should be aware of how such trials differ from investigator-initiated, grant-funded research. In particular, investigators should be cognizant of possible ethical conflicts in the care of patients, the development and analysis of data, and issues related to the dissemination of results.